Literature DB >> 2006244

Increased sensitivity to rate-altering and discriminative stimulus effects of morphine following continuous exposure to naltrexone.

A M Young1, S R Mattox, M D Doty.   

Abstract

Two experiments evaluated whether termination of a continuous infusion of naltrexone altered sensitivity to the rate-suppressing or discriminative stimulus effects of morphine in rats. An 8-day infusion of saline or doses of 3, 10, or 18 mg/kg/day naltrexone did not alter rates of lever pressing maintained under fixed-ratio 30 schedules of food delivery. A dose of 10 mg/kg day naltrexone produced insurmountable antagonism of the rate-suppressing and analgesic effects of morphine. The ED50 of morphine for rate suppression decreased by 2-fold 1 day after termination of the 8-day infusion of 10 or 18 mg/kg/day naltrexone. The ED50 of morphine returned to initial values within 8 days. Termination of infusion of either saline or 3 mg/kg/day naltrexone did not alter the ED50 of morphine. Changes in morphine stimulus control were evaluated in rats trained to discriminate saline and 3.2 mg/kg morphine under fixed-ratio 15 schedules of food delivery. The ED50 of morphine for stimulus control or rate suppression decreased by 2-fold 1 day after termination of an 8-day infusion of 18 mg/kg/day naltrexone. The ED50 of morphine for rate suppression returned to initial values within 3 days; that for stimulus control, within 5 days. Thus, termination of exposure to high doses of naltrexone produced brief changes in sensitivity to the rate-altering and discriminative stimulus effects of morphine that parallel reported changes in sensitivity to the analgesic and lethal effects of morphine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2006244     DOI: 10.1007/bf02244076

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Enhanced analgesic effects of morphine after chronic administration of naloxone in the rat.

Authors:  A H Tang; R J Collins
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

2.  Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine.

Authors:  M T Bardo; J L Neisewander
Journal:  Pharmacol Biochem Behav       Date:  1987-10       Impact factor: 3.533

3.  Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys.

Authors:  C P France; W H Morse
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

4.  Opiate receptor supersensitivity produced by chronic naloxone treatment: dissociation of morphine-induced antinociception and conditioned taste aversion.

Authors:  M T Bardo; J S Miller; M E Risner
Journal:  Pharmacol Biochem Behav       Date:  1984-10       Impact factor: 3.533

5.  Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment.

Authors:  A Tempel; R S Zukin; E L Gardner
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

6.  Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: biochemical and behavioral correlates.

Authors:  N Brunello; A Volterra; A M Di Giulio; V Cuomo; G Racagni
Journal:  Life Sci       Date:  1984-04-23       Impact factor: 5.037

7.  Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.

Authors:  B C Yoburn; R R Goodman; A H Cohen; G W Pasternak; C E Inturrisi
Journal:  Life Sci       Date:  1985-06-17       Impact factor: 5.037

8.  Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.

Authors:  M J Millan; B J Morris; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1988-11       Impact factor: 4.030

9.  An increase in opiate receptor-sites is associated with enhanced cardiovascular depressant, but not respiratory depressant action of morphine.

Authors:  A Pfeiffer; D G Pfeiffer; G Feuerstein; A I Faden; I J Kopin
Journal:  Brain Res       Date:  1984-04-02       Impact factor: 3.252

10.  Differential effects of chronic morphine and naloxone on opiate receptors, monoamines, and morphine-induced behaviors in preweanling rats.

Authors:  M T Bardo; R K Bhatnagar; G F Gebhart
Journal:  Brain Res       Date:  1982-06       Impact factor: 3.252

View more
  5 in total

1.  Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats.

Authors:  Farhana Sakloth; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2018-03-12       Impact factor: 3.157

2.  Pharmacological specificity of enhanced sensitivity to naltrexone in rats.

Authors:  C W Schindler; S R Goldberg; J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.

Authors:  C A Paronis; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

4.  Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.

Authors:  Tally M Largent-Milnes; Wenhong Guo; Hoau-Yan Wang; Lindsay H Burns; Todd W Vanderah
Journal:  J Pain       Date:  2008-05-12       Impact factor: 5.820

5.  Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.

Authors:  Sandra D Comer; Maria A Sullivan; Elmer Yu; Jami L Rothenberg; Herbert D Kleber; Kyle Kampman; Charles Dackis; Charles P O'Brien
Journal:  Arch Gen Psychiatry       Date:  2006-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.